Illumina, Inc. (NASDAQ: ILMN) and Sequenom, Inc. (NASDAQ: SQNM) today
announced they have agreed to settle all pending infringement claims and
other disputes between Sequenom and Verinata Health, Inc. The parties
will pool their owned and in-licensed intellectual property directed to
noninvasive prenatal testing (NIPT), including patents that will remain
the subject of ongoing interference proceedings.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.